Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (81-90 of 215) with videos related to

Pageof 22
Sort By:
Plos Pathogens|January 2, 2008
Progression of Plasmodium berghei through Anopheles stephensi is density-dependentRobert E Sinden, Emma J Dawes, Yasmene Alavi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparumPhilip Bejon, Jedidah Mwacharo, Oscar Kai, et al.
The American Journal of Tropical Medicine and Hygiene|July 15, 2005
Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trialsLaura Andrews, Rikke F Andersen, Daniel Webster, et al.
European Journal of Immunology|February 13, 2008
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium bergheiArturo Reyes-Sandoval, Saranya Sridhar, Tamara Berthoud, et al.
Plos One|August 21, 2014
4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaquesAlexandra J Spencer, Julie Furze, Jared D Honeycutt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virusRichard J Anderson, Carolyn M Hannan, Sarah C Gilbert, et al.
Human Vaccines|January 12, 2010
Prime-boost vectored malaria vaccines: progress and prospectsAdrian V S Hill, Arturo Reyes-Sandoval, Geraldine O'Hara, et al.
International Journal of Cancer|September 24, 2004
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.
European Journal of Immunology|April 17, 2013
Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccineCaitlin E Mullarkey, Amy Boyd, Arjan van Laarhoven, et al.
Antiviral Research|June 17, 2014
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambsNúria Busquets, Gema Lorenzo, Elena López-Gil, et al.
Pageof 22

Showing results (81-90 of 215) with videos related to

Sort By:
Pageof 22
Plos Pathogens|January 2, 2008
Progression of Plasmodium berghei through Anopheles stephensi is density-dependentRobert E Sinden, Emma J Dawes, Yasmene Alavi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparumPhilip Bejon, Jedidah Mwacharo, Oscar Kai, et al.
The American Journal of Tropical Medicine and Hygiene|July 15, 2005
Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trialsLaura Andrews, Rikke F Andersen, Daniel Webster, et al.
European Journal of Immunology|February 13, 2008
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium bergheiArturo Reyes-Sandoval, Saranya Sridhar, Tamara Berthoud, et al.
Plos One|August 21, 2014
4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaquesAlexandra J Spencer, Julie Furze, Jared D Honeycutt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virusRichard J Anderson, Carolyn M Hannan, Sarah C Gilbert, et al.
Human Vaccines|January 12, 2010
Prime-boost vectored malaria vaccines: progress and prospectsAdrian V S Hill, Arturo Reyes-Sandoval, Geraldine O'Hara, et al.
International Journal of Cancer|September 24, 2004
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.
European Journal of Immunology|April 17, 2013
Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccineCaitlin E Mullarkey, Amy Boyd, Arjan van Laarhoven, et al.
Antiviral Research|June 17, 2014
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambsNúria Busquets, Gema Lorenzo, Elena López-Gil, et al.
Pageof 22